"With this year quickly drawing to a close, the medical device industry has received little guidance about how to comply with the tax — causing significant uncertainty and confusion for businesses," the wrote. "As we work together to develop a long-term solution to help move our economy forward, reduce our debt and reform our tax code, we urge you to support delaying enactment of this provision in a fiscally responsible manner."
The Advanced Medical Technology Association (AdvaMed), which represents device makers, praised the senators' effort but said the tax must be fully repealed.
“We appreciate Sen. Klobuchar and Sen. Hagan’s leadership on this issue and also appreciate the broad bipartisan support for preventing the implementation of the device tax which is slated to go into effect Jan. 1," AdvaMed senior executive vice president of government affairs J.C. Scott said. "Delay of the tax is an important step, but Congress must fully address the device tax as it works to develop a long-term solution to help our economy more forward, reduce our debt and reform our tax code.”